Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04504669
Title First Time in Human Study of AZD8701 With or Without Durvalumab in Participants With Advanced Solid Tumours
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors AstraZeneca
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | FRA | ESP | CAN

Facility Status City State Zip Country Details
Research Site Baltimore Maryland 21287 United States Details
Research Site Saint Louis Missouri 63110 United States Details
Research Site Huntersville North Carolina 28078 United States Details
Research Site Franklin Tennessee 37067 United States Details
Research Site Houston Texas 77030 United States Details
Research Site Madison Wisconsin 53792 United States Details
Research Site Toronto Ontario M5G 2M9 Canada Details
Research Site Rennes 35000 France Details
Research Site Villejuif Cedex 94805 France Details
Research Site Barcelona 08035 Spain Details
Research Site L'Hospitalet de Llobregat 08907 Spain Details
Research Site Madrid 28027 Spain Details
Research Site Madrid 28041 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field